Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionFinancial Advisors Network, Inc.
Latest Disclosed Ownership155,861 shares
Latest Disclosed Value $ 21,722,321
Financial Advisors Network, Inc. reports 0.03% decrease in ownership of GILD / Gilead Sciences, Inc.

On May 14, 2026 - Financial Advisors Network, Inc. filed a 13F-HR form disclosing ownership of 155,861 shares of Gilead Sciences, Inc. (CH:GILD) valued at $21,722,321 USD as of March 31, 2026. The entity filed a previous 13F-HR on May 14, 2026 disclosing 155,901 shares of Gilead Sciences, Inc.. This represents a change in shares of -0.03% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F GILEAD SCIENCES COM 375558103 155,861 -40 -0.03 21,722 13.52 2.9993
2026-05-14 2025-12-31 13F GILEAD SCIENCES COM 375558103 155,901 34 0.02 19,135 10.60 2.6229
2025-11-14 2025-09-30 13F GILEAD SCIENCES COM 375558103 155,867 0 0.00 17,301 0.12 2.4504
2025-08-14 2025-06-30 13F GILEAD SCIENCES COM 375558103 155,867 -149 -0.10 17,281 -1.14 2.6093
2025-05-13 2025-03-31 13F GILEAD SCIENCES COM 375558103 156,016 -2,309 -1.46 17,482 19.54 2.8999
2025-02-14 2024-12-31 13F GILEAD SCIENCES COM 375558103 158,325 356 0.23 14,624 14.28 2.4336
2024-02-09 2023-12-31 13F GILEAD SCIENCES COM 375558103 157,969 24 0.02 12,797 8.12 2.5764
2023-11-15 2023-09-30 13F GILEAD SCIENCES COM 375558103 157,945 2,396 1.54 11,836 -11.36 2.6599
2023-02-02 2022-12-31 13F GILEAD SCIENCES COM 375558103 155,549 1 0.00 13,354 39.15 3.5361
2022-11-14 2022-09-30 13F GILEAD SCIENCES COM 375558103 155,548 0 0.00 9,596 -0.19 2.8356
2022-08-04 2022-06-30 13F GILEAD SCIENCES COM 375558103 155,548 0 0.00 9,614 3.97 2.6874
2022-05-13 2022-03-31 13F GILEAD SCIENCES COM 375558103 155,548 -12,482 -7.43 9,247 -24.21 2.2767
2022-02-11 2021-12-31 13F GILEAD SCIENCES COM 375558103 168,030 -978 -0.58 12,201 6.98 2.7446
2021-12-27 2021-09-30 13F GILEAD SCIENCES COM 375558103 169,008 -173 -0.10 11,405 -2.10 2.6269
2021-08-13 2021-06-30 13F GILEAD SCIENCES COM 375558103 169,181 -7,881 -4.45 11,650 1.80 3.4354
2021-05-14 2021-03-31 13F GILEAD SCIENCES COM 375558103 177,062 9,929 5.94 11,444 17.53 3.6952
2021-02-11 2020-12-31 13F GILEAD SCIENCES COM 375558103 167,133 157 0.09 9,737 -7.71 3.3455
2020-11-13 2020-09-30 13F GILEAD SCIENCES COM 375558103 166,976 -112 -0.07 10,551 -17.93 4.1313
2020-08-11 2020-06-30 13F GILEAD SCIENCES COM 375558103 167,088 -1,169 -0.69 12,856 2.20 5.2410
2020-05-11 2020-03-31 13F GILEAD SCIENCES COM 375558103 168,257 721 0.43 12,579 15.55 6.0003
2020-02-13 2019-12-31 13F GILEAD SCIENCES COM 375558103 167,536 14,558 9.52 10,886 12.27 4.9836
2019-11-12 2019-09-30 13F GILEAD SCIENCES COM 375558103 152,978 0 0.00 9,696 -0.78 4.9626
2019-08-09 2019-06-30 13F GILEAD SCIENCES COM 375558103 152,978 -14 -0.01 9,772 2.60 5.2538
2019-06-04 2019-03-31 13F GILEAD SCIENCES COM 375558103 152,992 -1,884 -1.22 9,524 -1.68 5.5194
2019-02-14 2018-12-31 13F GILEAD SCIENCES COM 375558103 154,876 9,859 6.80 9,687 -5.70 6.0295
2018-08-14 2018-06-30 13F GILEAD SCIENCES COM 375558103 145,017 17,687 13.89 10,273 12.62 6.2042
2018-02-07 2017-12-31 13F GILEAD SCIENCES COM 375558103 127,330 121,161 1,964.03 9,122 1,724.40 6.1604
2017-11-15 2017-09-30 13F GILEAD SCIENCES COM 375558103 6,169 -147 -2.33 500 11.86 0.3957
2017-08-04 2017-06-30 13F GILEAD SCIENCES COM 375558103 6,316 225 3.69 447 11.19 0.3709
2017-05-17 2017-03-31 13F GILEAD SCIENCES COM 375558103 6,091 -5,044,909 -99.88 402 -99.89 0.3479
2017-02-13 2016-12-31 13F GILEAD SCIENCES COM 375558103 5,051,000 5,051,000 360,337 0.3067
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.